<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Biogen Idec Announces First Patient Enrolled in the Global Phase III Study of PEGylated Interferon Beta-1a for Relapsing Multiple Sclerosis</title>
	<atom:link href="http://www.unitedspinal.org/msscene/2009/06/23/biogen-idec-announces-first-patient-enrolled-in-the-global-phase-iii-study-of-pegylated-interferon-beta-1a-for-relapsing-multiple-sclerosis/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.unitedspinal.org/msscene/2009/06/23/biogen-idec-announces-first-patient-enrolled-in-the-global-phase-iii-study-of-pegylated-interferon-beta-1a-for-relapsing-multiple-sclerosis/</link>
	<description>The larger view on multiple sclerosis</description>
	<lastBuildDate>Wed, 14 Apr 2010 19:26:02 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
</channel>
</rss>

